A study to evaluate the effect on pain relief and safety of a new treatment (ASP8477) with a mock treatment (placebo) in subjects with Peripheral Neuropathic Pain

Registry ID

EUCTR2013-002521-27

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Astellas Pharma Europe B.V. (APEB)

Start date

2014-02-23

Completion date

2015-02-13

Last update

2026-08-16

Conditions

• Peripheral Neuropathic Pain

Summary

To assess analgesic efficacy of ASP8477 relative to placebo in subjects with peripheral neuropathic pain as determined by the change in the average daily pain intensity in responders.

Locations

• , , Germany
• , , UK
• , , Czechia

Related clinical trials

• Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients
• Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
• Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
• Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain
• Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

View on source registry